Abstract
Five organotin complexes with general formulae [LCSSSnR2]n (R = Me, n-Bu, Ph) and R3SnLCSSSnR3 (R = n-Bu, Ph) were synthesized by the reaction of equimolar quantities of sarcosine (HLH) with KOH, CS2 and either R2SnCl2 (R = Me, n-Bu, Ph) or R3SnCl (R = n-Bu, Ph) in methanol. Elemental (CHNS) analyses data and mass spectroscopy agreed well with the molecular composition of the synthesized products. FTIR spectroscopy verified the monodentate binding mode of the carboxylate group and a bidentate chelating behavior of the dithiocarboxylate moiety of the ligand for binding with tin(IV). Thus, penta- and hexa-coordinated environments around tin were observed in the solid state in di- and triorganotin complexes, respectively. The penta-coordinated geometry in diorganotin(IV) product 2 was further verified by its single-crystal XRD analysis. The organotin moieties and ligand units were interconnected with each other alternately in hexameric cyclic arrangement. The number of protons found in 1H NMR spectra was in good agreement with those calculated by incremental method. Complexes were examined for their antioxidant, antimicrobial, antidiabetic, thrombolytic, hemolytic activities. The free ligand HLH was found inactive against all the four bacterial strains.
Similar content being viewed by others
References
Iqbal, M.; Ali, S.; Haider, A.; Khalid, N.: Therapeutic properties of organotin complexes with reference to their structural and environmental features. Rev. Inorg. Chem. 37(2), 51–70 (2017)
Ghazi, D.; Rasheed, Z.; Yousif, E.: Review of organotin compounds: chemistry and applications. Int. J. Res. Eng. Innov. 2(4), 340–348 (2018)
Jain, M.; Singh, V.; Singh, R.: Biologically potent sulphonamide imine complexes of organotin (IV): synthesis, spectroscopic characterization and biological screening. J. Iran. Chem. Soc. 1(1), 20–27 (2004)
Javed, F.; Sirajuddin, M.; Ali, S.; Khalid, N.; Tahir, M.N.; Shah, N.A.; Rasheed, Z.; Khan, M.R.: Organotin (IV) derivatives of o-isobutyl carbonodithioate: synthesis, spectroscopic characterization, X-ray structure, HOMO/LUMO and in vitro biological activities. Polyhedron 104, 80–90 (2016)
Saeed, A.; Channar, P.A.; Larik, F.A.; Jabeen, F.; Muqadar, U.; Saeed, S.; Flörke, U.; Ismail, H.; Dilshad, E.; Mirza, B.: Design, synthesis, molecular docking studies of organotin-drug derivatives as multi-target agents against antibacterial, antifungal, α-amylase, α-glucosidase and butyrylcholinesterase. Inorg. Chim. Acta 464, 204–213 (2017)
Hadi, S.; Noviany, N.; Rilyanti, M.: In vitro antimalarial activity of some organotin (IV) 2-nitrobenzoate compounds against Plasmodium falciparum. Maced. J. Chem. Chem. En. 37(2), 185–191 (2018)
Ali, S.; Shahzadi, S.: Anticarcinogenicity and toxicity of organotin (IV) complexes: a review. Iran. J. Sci. Technol. A 42(2), 505–524 (2018)
Adeyemi, J.; Onwudiwe, D.: Organotin (IV) dithiocarbamate complexes: chemistry and biological activity. Molecules 23(10), 2571 (2018)
Hussain, S.; Ali, S.; Shahzadi, S.; Nawaz, M.; Ramzan, S.; Shahid, M.: Synthesis, spectroscopic characterization, X-ray crystal structure and biological activities of homo- and heterobimetallic complexes with. Polyhedron 119, 483–493 (2016). https://doi.org/10.1016/j.poly.2016.08.016
Hussain, S.; Ali, S.; Shahzadi, S.; Rizzoli, C.; Shahid, M.: Diorganotin(IV) complexes with monohydrate disodium salt of iminodiacetic acid: synthesis, characterization, crystal structure and biological activities. J. Chin. Chem. Soc. 62(9), 793–802 (2015). https://doi.org/10.1002/jccs.201500274
Yousif, E.; Mehdi, B.I.; Yusop, R.; Salimon, J.; Salih, N.; Abdullah, B.M.: Synthesis, structure and antibacterial activity of some triorganotin (IV) complexes with a benzamidoalanine ligand. J. Taibah Univ. Sci. 8(3), 276–281 (2014)
Ghazi, D.; Yousif, E.: Design of organotin (IV) complexes derived from ciprofloxacin. Int. J. Res. Eng. Innov. 1(4), 63–65 (2017)
Mariam, S.; Hussain, S.; Ali, S.; Shahzadi, S.; Ramzan, S.; Shahid, M.: Homobimetallic (Sn, Sn) complexes with [2-dithiocarboxy (methyl) amino] acetic acid: synthesis, characterization and biological studies. Iran. J. Sci. Technol. A 42(3), 1277–1284 (2018)
Alama, A.; Tasso, B.; Novelli, F.; Sparatore, F.: Organometallic compounds in oncology: implications of novel organotins as antitumor agents. Drug Disc. Today 14(9–10), 500–508 (2009)
Nath, M.; Pokharia, S.; Yadav, R.: Organotin (IV) complexes of amino acids and peptides. Coord. Chem. Rev. 215(1), 99–149 (2001)
Baul, T.S.B.; Kehie, P.; Duthie, A.; Guchhait, N.; Raviprakash, N.; Mokhamatam, R.B.; Manna, S.K.; Armata, N.; Scopelliti, M.; Wang, R.: Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound. J. Inorg. Biochem. 168, 76–89 (2017)
Singh, N.; Kumar, K.; Srivastav, N.; Singh, R.; Kaur, V.; Jasinski, J.P.; Butcher, R.J.: Exploration of fluorescent organotin compounds of α-amino acid Schiff bases for the detection of organophosphorous chemical warfare agents: quantification of diethylchlorophosphate. New J. Chem. 42(11), 8756–8764 (2018)
Lara-Cerón, J.A.; Jiménez-Pérez, V.M.; Molina-Paredes, A.A.; Rasika Dias, H.; Chávez-Reyes, A.; Ram Paudel, H.; Ochoa, M.E.; Muñoz-Flores, B.M.: Luminescent silk fibroin with organotin compounds from amino acid schiff bases–microwave-assisted synthesis, chemo-optical characterization, cytotoxicity, and confocal microscopy. Eur. J. Inorg. Chem. 2017(21), 2818–2827 (2017)
Selvaganapathy, M.; Raman, N.: Pharmacological activity of a few transition metal complexes: A short review. J. Chem. Biol. Ther. 1(02), 2572-0406 (2016)
Ueland, P.M.; Midttun, Ø.; Windelberg, A.; Svardal, A.; Skålevik, R.; Hustad, S.: Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin. Chem. Lab. Med. 45(12), 1737–1745 (2007)
Perry, K.W.; Falcone, J.F.; Fell, M.J.; Ryder, J.W.; Yu, H.; Love, P.L.; Katner, J.; Gordon, K.D.; Wade, M.R.; Man, T.: Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs cortical brain areas. Neuropharmacology 55(5), 743–754 (2008)
Zhang, H.X.; Hyrc, K.; Thio, L.L.: The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. J. Physiol. 587(13), 3207–3220 (2009)
Khoo, L.E.; Goh, N.K.; Eng, G.; Whalen, D.J.; Hazell, A.: Synthesis, characterization and fungicidal activity of triphenyltin derivatives of sarcosine: crystal structures of [Ph3Sn (OCOCH2NH2CH3)2] Cl and [Ph3Sn (OCOCH2NH2CH3)2] NCS. Appl. Organomet. Chem. 9(8), 699–706 (1995)
Hussain, S.; Bukhari, I.H.; Ali, S.; Shahzadi, S.; Shahid, M.; Munawar, K.S.: Synthesis and spectroscopic and thermogravimetric characterization of heterobimetallic complexes with Sn(IV) and Pd(II); DNA binding, alkaline phosphatase inhibition and biological activity studies. J. Coord. Chem. (2015). https://doi.org/10.1080/00958972.2014.994515
Arafat, Y.; Ali, S.; Shahzadi, S.; Shahid, M.: Preparation, characterization, and antimicrobial activities of bimetallic complexes of sarcosine with Zn (II) and Sn (IV). Bioinorg. Chem. Appl. 2013, 1–7 (2013)
Chai, C.; Armarego, W.: Purification of laboratory chemicals, 5th edn. Butterworth Heinemann, Oxford (2003)
Hussain, S.; Ali, S.; Shahzadi, S.; Sharma, S.K.; Qanungo, K.; Shahid, M.; Jabbar, A.; Bukhari, I.H.: Organotin(IV) complexes with 5-aminoisophthalic acid: synthesis, characterization, theoretical study, and biological activities. Russ. J. Gen. Chem. 85(10), 2386–2394 (2015). https://doi.org/10.1134/S1070363215100266
Khaliq, M.; Riaz, M.; Kanwal, N.; Mahmood, I.; Khan, A.; Bokhari, T.H.; Afzal, M.: Evolution of cytotoxicity, antioxidant, and antimicrobial studies of sugarcane (Saccharum officinarum) roots extracts. J. Chem. Soc. Pak. 39(1), 152–160 (2017)
Idrees, S.; Sarfraz, R.A.; Riaz, M.; Khera, R.A.; Zia, A.; Hanif, M.A.; Suleman, M.: Evaluation of antidiabetic, antioxidant, antimicrobial and cytotoxicity properties of avena sativa roots extracts. Oxid. Commun. 40(2), 613–623 (2017)
Riaz, M.; Rasool, N.; Bukhari, I.; Shahid, M.; Zubair, M.; Rizwan, K.; Rashid, U.: In vitro antimicrobial, antioxidant, cytotoxicity and GC-MS analysis of Mazus goodenifolius. Molecules 17(12), 14275–14287 (2012)
Hussain, S.; Ali, S.; Shahzadi, S.; Tahir, M.N.; Shahid, M.: Synthesis, characterization, biological activities, crystal structure and DNA binding of organotin (IV) 5-chlorosalicylates. J. Coord. Chem. 68(14), 2369–2387 (2015)
Riaz, M.; Rasool, N.; Bukhari, I.; Zubair, M.; Shahid, M.; Bokhari, T.; Gull, Y.; Rizwan, K.; Iqbal, M.; Zia-Ul-Haq, M.: Antioxidant studies using sunflower oil as oxidant substrate and protective assay by Antirrhinum majus. Oxid. Commun. 36(1), 272–282 (2013)
Lordan, S.; Smyth, T.J.; Soler-Vila, A.; Stanton, C.; Ross, R.P.: The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts. Food Chem. 141(3), 2170–2176 (2013)
Ali, M.S.; Amin, M.R.; Kamal, C.M.I.; Hossain, M.A.: In vitro antioxidant, cytotoxic, thrombolytic activities and phytochemical evaluation of methanol extract of the A. philippense L. leaves. Asian Pac. J. Trop. Biomed. 3(6), 464–469 (2013)
PRO, A.C.: Agilent technologies, Yarnton, England (2012).
Sheldrick, G.M.: A short history of SHELX. Acta Crystallogr. Sect. A Found. Crystallogr. 64(1), 112–122 (2008)
Farrugia, L.J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45(4), 849–854 (2012)
Farrugia, L.J.: WinGX suite for small-molecule single-crystal crystallography. J. Appl. Crystallogr. 32(4), 837–838 (1999)
Bonati, F.; Ugo, R.: Organotin (iv) n, n-disubstituted dithiocarbamates. J. Organomet. Chem. 10(2), 257–268 (1967)
Javed, F.; Ali, S.; Shahzadi, S.; Sharma, S.K.; Qanungo, K.; Tahir, M.N.; Shah, N.A.; Khan, M.R.; Khalid, N.: Synthesis, structural characterization, theoretical calculations and in vitro biological activities of organotin (IV) complexes with [O, O] donor ligand. J. Inorg. Organomet. P. 26(1), 48–61 (2016)
Hussain, S.; Ali, S.; Shahzadi, S.; Shahid, M.; Tahir, A.A.; Mustansar Abbas, S.; Riaz, M.; Ahmad, I.; Hussain, I.: Multinuclear (Sn/Pd) complexes with disodium 2, 2′-(dithiocarboxyazanediyl) diacetate hydrate; synthesis, characterization and biological activities. J. Coord. Chem. 70(24), 4070–4092 (2017)
Tweedy, B.: Plant extracts with metal ions as potential antimicrobial agents. Phytopathology 55, 910–914 (1964)
Parveen, B.; Bukhari, I.H.; Hussain, S.; Ali, K.G.; Shahid, M.: Synthesis and spectroscopic characterization of mononuclear/binuclear organotin (IV) complexes with 1H-1, 2, 4-triazole-3-thiol: comparative studies of their antibacterial/antifungal potencies. J. Serbian Chem. Soc. 80(6), 755–766 (2015)
Shi, Y.; Zhang, B.-Y.; Zhang, R.-F.; Zhang, S.-L.; Ma, C.-L.: Syntheses, characterizations, crystal structures, and in vitro antitumor activities of chiral triorganotin (IV) complexes containing (S)-(+)-2-(4-isobutyl-phenyl) propionic and (R)-(+)-2-(4-hydroxyphenoxy) propionic acid ligands. J. Coord. Chem. 65(23), 4125–4136 (2012)
Bnouham, M.; Ziyyat, A.; Mekhfi, H.; Tahri, A.; Legssyer, A.: Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research (1990-2000). Int. J. Diabetes Metab. 14, 1–25 (2006)
Ali, M.; Salim Hossain, M.; Islam, M.; Arman, S.I.; Sarwar Raju, G.; Dasgupta, P.; Noshin, T.F.: Aspect of thrombolytic therapy: a review. Sci. World J. 2014, 1–8 (2014)
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hussain, S., Ali, S., Shahzadi, S. et al. Synthesis, Structural and Biological Studies of Organotin(IV) Complexes with N-(Dithiocarboxy) Sarcosine. Arab J Sci Eng 45, 4785–4795 (2020). https://doi.org/10.1007/s13369-020-04496-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13369-020-04496-5